Standard Medication Reconciliation Protocol in the Primary Care Office-based Setting
NCT ID: NCT01577602
Last Updated: 2013-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
424 participants
INTERVENTIONAL
2011-10-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* giving patients a printed list of medications before the visit
* asking the patients about their medications with a scripted, open ended question.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Pre-Consultation Medication Reconciliation Service in Reducing Unintentional Medication Discrepancies During Transition of Care From Hospital Discharge to Primary Care Setting
NCT03181906
Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge
NCT01179867
Medication Reconciliation in Hospitalized CKD Patients : a Quasi-Experimental Study
NCT06819527
Multi-Center Medication Reconciliation Quality Improvement Study
NCT01337063
APHID- Primary Care Accuracy Study
NCT02135731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Providing patients a paper copy of their EMR medication list upon check-in, to review for accuracy prior to their office visit, will improve the agreement between the EMR medication list and patient report during a phone interview within one week of the office visit.
2. The medical assistant practice of routinely using an open-ended question to introduce the medication review will improve the agreement between the EMR medication list and patient report during a phone interview within one week of the office visit.
The main outcome measure for this study is full agreement of prescription medications between the medication list in the electronic medical record at the conclusion of patient's office visit and the list generated by pharmacists during a phone interview performed within a week of the office visit.
The study will take place at 2-4 Cleveland Clinic Health Centers in primary care offices. A sample size of 400 patients will be enrolled: 20 pairs of physicians and medical assistants will be invited to volunteer for the study, and 20 patients per MD/MA pair will be recruited. Medical assistants will be trained in using scripted open-ended questions to begin reviewing medications with patients. The study coordinator will implement the printed list intervention by providing a paper list to patients.
Consenting patients will be randomized to one of four groups (A-D):
A: NO patient review of printed medication list \& NO open-ended question B: Patient review of printed medication list ONLY C: Open-ended question ONLY D: BOTH patient review of printed medication list \& open-ended question
To document the medications that patients report taking, a pharmacist will conduct a detailed phone interview with the patient and/or caretaker within a week of the office visit using a prepared script. The pharmacist will note any discrepancies between the EMR and the patient's/caretaker's self report. In order to be considered in full agreement, the medication list and patient report must agree on the five following elements: 1) name, 2) dose, 3) frequency, 4) route, and 5) PRN status.
Our goal is to statistically test whether the proportion of medication lists in agreement with patient report differs in the intervention group compared to the non-intervention group. First, an unadjusted analysis utilizing a difference of proportions test and linear contrasts as described in the above planned comparisons. Then, a multivariable mixed model will be used to determine the significance of the intervention with adjustment.
If the interventions are successful, they will be incorporated into a standard medication reconciliation protocol for Cleveland Clinic primary care office practice. If highly successful, this protocol could serve as a new standard for medication reconciliation in outpatient primary care practice in the United States.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard practice
No interventions assigned to this group
Printed list intervention
Providing patients a list of their current medications before they see medical assistant and begin their visit.
Printed medication list
Provide a list of patient's current medication list as noted in the EMR
Open ended question intervention
Medical assistants begin the medication review with a scripted, open ended question (i.e., "tell me about your medications")
Open ended question
medical assistants begin medication reconciliation with a scripted open ended question.
Combined intervention
Combined intervention
Combines the printed medication list with the open ended question
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Printed medication list
Provide a list of patient's current medication list as noted in the EMR
Open ended question
medical assistants begin medication reconciliation with a scripted open ended question.
Combined intervention
Combines the printed medication list with the open ended question
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking
* Current medication list has at least 2 medications listed
Exclusion Criteria
* English is not primary language
* Less than 2 medications on medication list
Enrollment only applies to one visit. Patients cannot be enrolled more than one time on the study.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Hickner
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Hickner, MD, MSc
Role: STUDY_DIRECTOR
The Cleveland Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-667
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.